Indian markets have been bearish for a prolonged period, causing concern among investors. It's not just quarterly earnings; several global factors are influencing the markets and could continue to do so in the near term. ETMarkets spoke with Abhishek …

DUBLIN, IRELAND , Jan. 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 third quarter financial results at 9:00 a.m. ET on February 6, 2025. The …

… developments could drastically reduce capital expenditure,” Mahony said. “However, … of oil, banking, pharmaceuticals and mining left it … 10.3% in the third quarter, while current trading has … the consumer sector, [the third quarter] saw a more challenging …

… developments could drastically reduce capital expenditure,” Mahony said. “However, … of oil, banking, pharmaceuticals and mining left it … 10.3% in the third quarter, while current trading has … the consumer sector, [the third quarter] saw a more challenging …

… Merchandise exports till the third quarter of fiscal 2024-25 ( … 111 crore for capital expenditure. This would be 3 … effectiveness to cater to pharmaceutical and patient requirements. … effectiveness to cater to pharmaceutical and patient requirements. Gregory …

Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter and nine months ended December 31, 2024. The information mentioned in this release is based on …

… Market closes) 2025 Q3 Financial Results (as … expenses and capital expenditure requirements. Special consideration … of clinical and pharmaceutical development, including further … the assessment of preclinical, pharmacokinetic, carcinogenicity, toxicity, …

… invests in various fields including pharmaceuticals and foods, while JTI is … noted the investment covers capital expenditures, sales promotions, and research and … sales grew 40% in the third quarter of 2024 JT Group director …

The global surgical equipment market size was valued at $35.6 billion in 2022, and is projected to reach $59 billion by 2032, growing at a CAGR of 5.2%. PORTLAND, OR, UNITED STATES, January 28, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research …

… develop, the FTSE 100 pharmaceutical said. Over at … million passengers over the third quarter, the results also showed … its turnaround on higher third quarter constant currency revenue, but … data and personal consumption expenditures figures. Overnight, Asian …